Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla.

scientific article

Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MRM.26635
P932PMC publication ID5697655
P698PubMed publication ID28244131

P50authorEleanor J. BarnesQ32637041
Michael PavlidesQ43405332
William T ClarkeQ64947588
Christina LevickQ81401925
P2093author name stringChristopher T Rodgers
Matthew D Robson
Ladislav Valkovič
Lucian A B Purvis
Jeremy F Cobbold
P2860cites workBiliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy studyQ28344367
The Generalization of `Student's' Problem when Several Different Population Variances are InvolvedQ30053530
Human cardiac 31P magnetic resonance spectroscopy at 7 TeslaQ30433854
Coil combination for receive array spectroscopy: Are data-driven methods superior to methods using computed field maps?Q30487745
The burden of liver disease in Europe: a review of available epidemiological dataQ30590517
BISTRO: an outer-volume suppression method that tolerates RF field inhomogeneity.Q30653021
Cramér-Rao bounds: an evaluation tool for quantitationQ30654307
Repeatability of (31) P MRSI in the human brain at 7 T with and without the nuclear Overhauser effectQ31030888
MR spectroscopy of the liver: principles and clinical applications.Q33517208
The NMR phased arrayQ34279090
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic modelsQ34410029
In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allograftsQ35350908
Phospholipid metabolites as indicators of cancer cell functionQ35538301
Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C.Q35770548
Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutionsQ36895806
The trouble with quality filtering based on relative Cramér-Rao lower boundsQ38370857
Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengthsQ41095338
The variation of pathological changes in the liver evaluated by double biopsiesQ41434143
Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liverQ41598538
Sampling Variability on Percutaneous Liver BiopsyQ41604098
Characterization of the peak at 2.06 ppm in (31) P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?Q41717341
A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.Q42286656
Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decouplingQ42959190
Etiology and functional status of liver cirrhosis by 31P MR spectroscopyQ43083187
Receive array magnetic resonance spectroscopy: Whitened singular value decomposition (WSVD) gives optimal Bayesian solutionQ43107465
Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI.Q43589403
Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T.Q43863042
Adenine nucleotide content of human liver. Normal values and fructose-induced depletionQ43965684
Abnormal hepatic energy homeostasis in type 2 diabetesQ44899671
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.Q44964478
Phosphodiesters in the liver: the effect of field strength on the 31P signalQ45105644
Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo.Q45969259
Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liverQ46159096
Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy studyQ46369805
Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experimentQ46971368
Feasibility of liver weight estimation by postmortem computed tomography images: an autopsy studyQ47447604
Sampling variability of liver fibrosis in chronic hepatitis C.Q48583601
One-dimensional image-selected in vivo spectroscopy localized phosphorus saturation transfer at 7T.Q51118845
Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases.Q51583663
Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part II: Muscle, liver, kidney.Q51593287
Ultrashort TE chemical shift imaging (UTE-CSI).Q51979467
Standard liver volume in the Caucasian population.Q52205356
31P MRSI and 1H MRS at 7 T: initial results in human breast cancerQ57096859
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver DiseaseQ58622754
[The effect of nutritional status on the 31P MR spectrum of the normal liver]Q68481310
Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liverQ69877786
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearancesQ72511278
31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver diseaseQ72511313
Ternary and Quaternary Aqueous Systems Containing Bile Salt, Lecithin, and CholesterolQ72921002
Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imagingQ73029507
A new method for absolute quantitation of MRS metabolitesQ73585100
Improved preservation solutions for organ storage: a dynamic study of hepatic metabolismQ78164630
Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopyQ80655378
Liver biopsyQ83395480
A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased statesQ85200802
Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scannerQ86999725
In vivo (31)P magnetic resonance spectroscopy of the human liver at 7 T: an initial experienceQ87421186
Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver diseaseQ87476143
P433issue6
P304page(s)2095-2105
P577publication date2017-02-28
P1433published inMagnetic Resonance in MedicineQ6731496
P1476titlePhosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla
P478volume78

Reverse relations

cites work (P2860)
Q57020624Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age
Q47191918Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.
Q88085964Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs
Q64071539Feasibility of absolute quantification for P MRS at 7 T
Q33817177In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.
Q90683753Low SAR 31 P (multi-echo) spectroscopic imaging using an integrated whole-body transmit coil at 7T
Q42362596OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB.
Q48122478Using a whole-body 31P birdcage transmit coil and 16-element receive array for human cardiac metabolic imaging at 7T.

Search more.